Aniara
 
 

Enzyme Immuno Assays for the exploration of fibrinolysis

 
ZYMUTEST TAFI Ag
For Research Use Only in the United States and Canada

Immuno Assays products are available worldwide

Two-site ELISA method for the measurement of TAFI antigen (Thrombin Activatable Fibrinolysis Inhibitor). Assay designed with a Murine monoclonal antibody specific for TAFI, for coating, and a goat polyclonal antibody labeled with a Horse Radish Peroxidase (HRP) marker. Assay calibrator has a defined concentration of TAFI Ag, expressed as % of normal pooled human plasma, and exactly determined with three selected human plasma pools. TAFI and TAFIa are identically measured.

Assay characteristics
Kit components
Applications
Total Assay Time:                                                     3h15
Detection Threshold:                                                  ≤ 5%
Dynamic Range:                                         1 to 100 ng/mL
Intra-Assay CV:                                                        3-8%
Inter-Assay CV:                                                      5-10%
12x8 test kit
2x Sample Diluent
3x Plasma TAFI Calibrator
Plasma Controls (1x high & 1x low)
3x Anti-h-TAFI-HRP IC
1x Conjugate Diluent
1x Wash Solution
1x TMB
1x 0.45M Sulfuric Acid
High TAFI Ag concentrations involve a hypofibrinolytic status, which can induce an elevated risk of thrombosis.
Measurement of TAFI Ag on plasma in order to diagnose a risk of a hypofibrinolysis resulting from an excess of TAFI.

Streamline laboratory procedures! Click here for ready-to-use reagents and buffers, from Medicago AB. Available in tablets and pouches!

INFORMATION
SKU ID # Packaging Package Inserts MSDS Adaptations Price
ARK008A 12x8 test kit $695.00
ORDER NOW

Back to Enzyme Immuno Assays for the exploration of fibrinolysis




Company I Products I How To Order I Technical Data & Documentation I Research Discount I Industry Resources
Contact Us I Site Map I Home I Terms & Conditions I Privacy Policy

Design and Support Services by Liaison Marketing Communications.